Unity Biotechnology (STU:9U90) Accounts Payable & Accrued Expense : €6.05 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Accounts Payable & Accrued Expense?

Unity Biotechnology's quarterly accounts payable & accrued expense declined from Sep. 2023 (€6.00 Mil) to Dec. 2023 (€2.33 Mil) but then increased from Dec. 2023 (€2.33 Mil) to Mar. 2024 (€6.05 Mil).

Unity Biotechnology's annual accounts payable & accrued expense increased from Dec. 2021 (€3.51 Mil) to Dec. 2022 (€3.79 Mil) but then declined from Dec. 2022 (€3.79 Mil) to Dec. 2023 (€2.33 Mil).

Unity Biotechnology Accounts Payable & Accrued Expense Historical Data

The historical data trend for Unity Biotechnology's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Accounts Payable & Accrued Expense Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

7.29

3.75

3.51

3.79

2.33

Unity Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															6.36	6.34	6.00	2.33	6.05

Unity Biotechnology Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines